Pseudobufarenogin
CAS No. 17008-69-4
Pseudobufarenogin ( ψ-Bufarenogin )
Catalog No. M23765 CAS No. 17008-69-4
Pseudobufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 225 | In Stock |
|
10MG | 331 | In Stock |
|
25MG | 561 | In Stock |
|
50MG | 798 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePseudobufarenogin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPseudobufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
-
DescriptionPseudobufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
-
Synonymsψ-Bufarenogin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17008-69-4
-
Formula Weight416.5
-
Molecular FormulaC24H30O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC[C@]([C@H](CC1)C(C=C2)=COC2=O)([C@H](C([C@@H]([C@H]2CC3)[C@@](C)(CC4)[C@H]3C[C@H]4O)=O)O)[C@@]12O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ding J, et al. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. Oncotarget. 2015 May 10;6(13):11627-39.
molnova catalog
related products
-
Meclocycline sulfosa...
Meclocycline (INN) is a tetracycline antibiotic. It is used topically (i.e. for skin infections) as it is totally insoluble in water and may cause liver and kidney damage if given systemically.
-
Sulbentine
Sulbentine is an antifungal agent.
-
Galangin
Galangin is an agonist/antagonist of the arylhydrocarbon receptor, and also shows inhibition of CYP1A1 activity.